GSK raises profit outlook on strong vaccine and HIV drug sales
Quarterly results beat expectations and signal strong start for pharma group
Full Article
GSK raises profit outlook on strong vaccine and HIV drug sales
FT.com
0 shares
1 views
You might like
Related news coverage
GSK raises 2024 guidance after strong vaccine sales
In its first quarter, British company GSK said sales rose 10 per cent to £7.4bn but total operating profit fell 18 per cent to..
City A.M.